TY  - GEN 
AU  - M. El-Hammadi, Mazen
AU  - Arias Mediano, José Luis
PY  - 2022
UR  - https://hdl.handle.net/10481/94503
AB  - Therapeutics are habitually characterized by short plasma half-lives and little affinity for
targeted cells. To overcome these challenges, nanoparticulate systems have entered into the disease
arena. Poly(D,L-lactide-co-glycolide) (PLGA) is one of...
LA  - eng
PB  - MDPI
KW  - active drug targeting
KW  - ligand-mediated targeting
KW  - nanoparticle
TI  - Recent Advances in the Surface Functionalization of PLGA-Based Nanomedicines
DO  - 10.3390/nano12030354
ER  -